Search Results

You are looking at 1 - 9 of 9 items for :

  • "non-clear cell renal cell carcinoma" x
Clear All
Full access

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Featured Updates to the NCCN Guidelines

Robert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, Naomi Haas, Michael R. Harrison, Elizabeth R. Plimack, Jeffrey Sosman, Neeraj Agarwal, Sam Bhayani, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Thomas H. Gallagher, Steven L. Hancock, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, Bryan Lewis, Brandon Manley, Brittany McCreery, Andrew McDonald, Amir Mortazavi, Phillip M. Pierorazio, Lee Ponsky, Bruce G. Redman, Bradley Somer, Geoffrey Wile, Mary A. Dwyer, CGC, Lydia J. Hammond and Griselda Zuccarino-Catania

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non–clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

Full access

Elizabeth R. Plimack and Gary R. Hudes

patients with metastatic non-clear cell renal cell carcinoma . Invest New Drugs , in press . 35 Plimack ER Jonasch E Bekele BN . Sunitinib in papillary renal cell carcinoma (pRCC): results from a single-arm phase II study [abstract] . Presented at the

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Kanishka Sircar, Brad Somer, Jue Wang, Richard B. Wilder, Mary A. Dwyer and Rashmi Kumar

patients with non-clear cell renal cell carcinoma refractory to VEGF-targeted therapy: subgroup analysis of REACT [abstract] . J Clin Oncol 2012 ; 30 ( Suppl ): Abstract 402 . 11. Larkin JM Fisher RA Pickering LM . Chromophobe renal cell

Full access

Daniel Y. C. Heng and Toni K. Choueiri

E Bekele BN . Sunitinib in non-clear cell renal cell carcinoma (ncc-RCC): a phase II study [abstract] . J Clin Oncol 2008 ; 26 ( Suppl 1 ): Abstract 5112 . 20 Gore ME Porta C Oudard S . Sunitinib in metastatic renal cell carcinoma

Full access

Pablo Maroto, Georgia Anguera, Juan Maria Roldan-Romero, Maria Apellániz-Ruiz, Ferran Algaba, Jacqueline Boonman, Mark Nellist, Cristina Montero-Conde, Alberto Cascón, Mercedes Robledo and Cristina Rodríguez-Antona

discussed in this article or their competitors. See JNCCN.org for supplemental online content. References 1. Kroeger N Xie W Lee JL . Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents

Full access

Eric Jonasch

: 1103 – 1115 . 10.1056/NEJMoa1816047 6. McDermott DF , Lee JL , Ziobro M , First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma: results from KEYNOTE-427 cohort B [abstract] . J Clin Oncol 2019 ; 37 ( Suppl

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer and Rashmi Kumar

in metastatic papillary and chromophobe renal cell carcinoma . J Clin Oncol 2008 ; 26 : 127 – 131 . 162. Tannir NM Plimack E Ng C . A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma . Eur Urol

Full access

NCCN Guidelines Insights: Kidney Cancer, Version 1.2021

Featured Updates to the NCCN Guidelines

Robert J. Motzer, Eric Jonasch, Shawna Boyle, Maria I. Carlo, Brandon Manley, Neeraj Agarwal, Ajjai Alva, Katy Beckermann, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Christos Kyriakopoulos, Elaine T. Lam, Clayton Lau, Bryan Lewis, David C. Madoff, Brittany McCreery, M. Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Phillip M. Pierorazio, Elizabeth R. Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Bradley Somer, Jeffrey Sosman, Mary A. Dwyer and Angela D. Motter

Velasco G , McKay RR , Lin X , . Comprehensive analysis of survival outcomes in non-clear cell renal cell carcinoma patients treated in clinical trials . Clin Genitourin Cancer 2017 ; 15 : 652 – 660.e651 . 10.1016/j.clgc.2017.03.004 15. Hutson

Full access

Matthew Zibelman and Elizabeth R. Plimack

Schulz KF . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials . J Clin Epidemiol 2010 ; 63 : e1 – 37 . 21. Kroeger N Xie W Lee JL . Metastatic non–clear cell renal cell carcinoma